BRPI1007211A2 - composição farmacêutica oral em uma forma sólida, e, processo para preparar uma composição. - Google Patents
composição farmacêutica oral em uma forma sólida, e, processo para preparar uma composição.Info
- Publication number
- BRPI1007211A2 BRPI1007211A2 BRPI1007211A BRPI1007211A BRPI1007211A2 BR PI1007211 A2 BRPI1007211 A2 BR PI1007211A2 BR PI1007211 A BRPI1007211 A BR PI1007211A BR PI1007211 A BRPI1007211 A BR PI1007211A BR PI1007211 A2 BRPI1007211 A2 BR PI1007211A2
- Authority
- BR
- Brazil
- Prior art keywords
- composition
- preparing
- solid form
- oral pharmaceutical
- pharmaceutical composition
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 239000008203 oral pharmaceutical composition Substances 0.000 title 1
- 239000007787 solid Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4015—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/40—Cyclodextrins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Pulmonology (AREA)
- Addiction (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Psychology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Immunology (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Inorganic Chemistry (AREA)
- Urology & Nephrology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP09100084 | 2009-01-29 | ||
| PCT/EP2010/050893 WO2010086315A1 (en) | 2009-01-29 | 2010-01-27 | Pharmaceutical compositions comprising 2-oxo-1-pyrrolidine derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI1007211A2 true BRPI1007211A2 (pt) | 2019-09-24 |
Family
ID=40668146
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI1007211A BRPI1007211A2 (pt) | 2009-01-29 | 2010-01-27 | composição farmacêutica oral em uma forma sólida, e, processo para preparar uma composição. |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20110275693A1 (pt) |
| EP (1) | EP2391351B1 (pt) |
| JP (1) | JP5599115B2 (pt) |
| KR (1) | KR101665001B1 (pt) |
| CN (2) | CN104906085A (pt) |
| AU (1) | AU2010209790B2 (pt) |
| BR (1) | BRPI1007211A2 (pt) |
| CA (1) | CA2747396C (pt) |
| DK (1) | DK2391351T3 (pt) |
| EA (1) | EA022080B1 (pt) |
| ES (1) | ES2520990T3 (pt) |
| HK (1) | HK1209649A1 (pt) |
| IL (1) | IL213546A0 (pt) |
| MX (1) | MX2011007451A (pt) |
| PL (1) | PL2391351T3 (pt) |
| WO (1) | WO2010086315A1 (pt) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2346500B1 (en) | 2008-10-16 | 2017-05-17 | The Johns Hopkins University | Methods and compositions for improving cognitive function |
| KR101640164B1 (ko) * | 2009-01-29 | 2016-07-15 | 유씨비 파마, 에스.에이. | ２옥소１피롤리딘 유도체를 포함하는 약학적 조성물 |
| US10154988B2 (en) | 2012-11-14 | 2018-12-18 | The Johns Hopkins University | Methods and compositions for treating schizophrenia |
| CA2904767C (en) | 2013-03-15 | 2022-06-21 | Agenebio, Inc. | Methods and compositions for improving cognitive function |
| US10806717B2 (en) | 2013-03-15 | 2020-10-20 | The Johns Hopkins University | Methods and compositions for improving cognitive function |
| CN104800176A (zh) * | 2015-04-23 | 2015-07-29 | 广东赛烽医药科技有限公司 | 一种布瓦西坦口崩片及其制备方法 |
| EA034167B8 (ru) | 2015-05-22 | 2021-04-27 | Эйджинбайо, Инк. | Фармацевтические композиции леветирацетама пролонгированного высвобождения |
| CN106902358B (zh) | 2015-12-21 | 2020-07-10 | 广州市香雪制药股份有限公司 | 口服制剂及其制备方法 |
| EP3397253A1 (en) | 2015-12-30 | 2018-11-07 | Adamas Pharmaceuticals, Inc. | Methods and compositions for the treatment of seizure-related disorders |
| CN111374956A (zh) * | 2018-12-28 | 2020-07-07 | 上海迪赛诺生物医药有限公司 | 改进的布瓦西坦速释制剂 |
| EP4431086A1 (en) | 2023-03-16 | 2024-09-18 | Adalvo Limited | Pharmaceutical composition comprising (2s)-2-[(4r)-2-oxo-4-propyltetrahydro-1h-pyrrol-1-yl]butanamide |
| EP4491177A1 (en) | 2023-07-14 | 2025-01-15 | Sanovel Ilac Sanayi ve Ticaret A.S. | Film coated tablets of brivaracetam |
| EP4491176A1 (en) | 2023-07-14 | 2025-01-15 | Sanovel Ilac Sanayi ve Ticaret A.S. | A film coated tablet comprising brivaracetam |
| EP4527378A1 (en) | 2023-09-22 | 2025-03-26 | Sanovel Ilac Sanayi ve Ticaret A.S. | A film coated tablet of brivaracetam |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5595761A (en) * | 1994-01-27 | 1997-01-21 | The Board Of Regents Of The University Of Oklahoma | Particulate support matrix for making a rapidly dissolving tablet |
| AP2003002900A0 (en) * | 2001-05-01 | 2003-12-31 | Pfizer Prod Inc | Method for manufacturing a low dose pharmaceutical composition |
| JP2005298338A (ja) * | 2002-02-27 | 2005-10-27 | Eisai Co Ltd | 速崩壊性圧縮成形製剤 |
| EP1731149A1 (en) * | 2005-06-08 | 2006-12-13 | Ucb S.A. | Use of 2-oxo-1-pyrrolidone derivatives for the treatment of diseases characterized by progressive myoclonic epilepsy |
| EP2041084B1 (en) * | 2006-06-08 | 2013-11-06 | UCB Pharma, S.A. | Co-crystals of pyrrolidinones |
| KR101640164B1 (ko) * | 2009-01-29 | 2016-07-15 | 유씨비 파마, 에스.에이. | ２옥소１피롤리딘 유도체를 포함하는 약학적 조성물 |
-
2010
- 2010-01-27 AU AU2010209790A patent/AU2010209790B2/en not_active Ceased
- 2010-01-27 BR BRPI1007211A patent/BRPI1007211A2/pt not_active IP Right Cessation
- 2010-01-27 ES ES10701246.0T patent/ES2520990T3/es active Active
- 2010-01-27 WO PCT/EP2010/050893 patent/WO2010086315A1/en not_active Ceased
- 2010-01-27 EA EA201101118A patent/EA022080B1/ru not_active IP Right Cessation
- 2010-01-27 PL PL10701246T patent/PL2391351T3/pl unknown
- 2010-01-27 JP JP2011546826A patent/JP5599115B2/ja not_active Expired - Fee Related
- 2010-01-27 KR KR1020117019929A patent/KR101665001B1/ko not_active Expired - Fee Related
- 2010-01-27 MX MX2011007451A patent/MX2011007451A/es active IP Right Grant
- 2010-01-27 EP EP10701246.0A patent/EP2391351B1/en active Active
- 2010-01-27 CN CN201510244092.2A patent/CN104906085A/zh active Pending
- 2010-01-27 US US13/144,895 patent/US20110275693A1/en not_active Abandoned
- 2010-01-27 DK DK10701246.0T patent/DK2391351T3/da active
- 2010-01-27 CN CN2010800056825A patent/CN102300562A/zh active Pending
- 2010-01-27 CA CA2747396A patent/CA2747396C/en not_active Expired - Fee Related
-
2011
- 2011-06-14 IL IL213546A patent/IL213546A0/en unknown
-
2015
- 2015-10-28 HK HK15110623.7A patent/HK1209649A1/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MX2011007451A (es) | 2011-08-03 |
| CN104906085A (zh) | 2015-09-16 |
| JP5599115B2 (ja) | 2014-10-01 |
| CN102300562A (zh) | 2011-12-28 |
| ES2520990T3 (es) | 2014-11-12 |
| KR101665001B1 (ko) | 2016-10-11 |
| JP2012516303A (ja) | 2012-07-19 |
| EA201101118A1 (ru) | 2012-03-30 |
| AU2010209790A1 (en) | 2011-08-18 |
| IL213546A0 (en) | 2011-07-31 |
| PL2391351T3 (pl) | 2015-02-27 |
| CA2747396C (en) | 2015-12-08 |
| EA022080B1 (ru) | 2015-10-30 |
| WO2010086315A1 (en) | 2010-08-05 |
| CA2747396A1 (en) | 2010-08-05 |
| KR20120008023A (ko) | 2012-01-25 |
| US20110275693A1 (en) | 2011-11-10 |
| AU2010209790B2 (en) | 2014-01-16 |
| EP2391351B1 (en) | 2014-08-20 |
| HK1209649A1 (en) | 2016-04-08 |
| DK2391351T3 (da) | 2014-12-01 |
| EP2391351A1 (en) | 2011-12-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0905717A2 (pt) | Composição farmacêutica, processo para preparar uma composição farmacêutica e forma de dosagem farmacêutica | |
| BRPI1007161A2 (pt) | composição farmacêutica oral, e processo para preparar uma composição | |
| BRPI0914918A2 (pt) | forma de dosagem farmacêutica, e, método para preparar uma forma de dosagem sólida. | |
| BRPI0912384A2 (pt) | composição, e, método para preparar uma composição | |
| BRPI0908092A2 (pt) | Edulcorante, método para preparar uma composição edulcorante, e, composição edulcorante | |
| BRPI0921718A2 (pt) | composição, método para produzir uma composição, e, artigo moldado | |
| BRPI0909691A8 (pt) | composto, método para preparar um composto, e, composição farmacêutica | |
| BRPI0814299A2 (pt) | Preparação sólida, e, métodos para estabilizar um composto em uma preparação sólida, e para produzir uma preparação sólida | |
| BRPI1016132A2 (pt) | composição, formulação farmacêutica, método para fabricar uma formulação farmacêutica estável. | |
| BR112012002102A2 (pt) | composição farmaceutica e metodo para preparar uma composição farmaceutica | |
| BR112012004864A2 (pt) | composição particulada , processo para produzir uma composição particulada, e , material pulverulento | |
| BRPI0821858A2 (pt) | Composto, composição para cuidado oral, e, método | |
| BRPI0909122A2 (pt) | métodos para produzir produtos estiráveis. | |
| BR112014015042A8 (pt) | composição farmacêutica, e, método para obter uma composição radiofarmacêutica | |
| BRPI0818680A2 (pt) | composição farmacêutica, preparação farmacêutica, e método para preparar um forma de dosagem oral farmacêutica | |
| BR112012015100A2 (pt) | composição de polímero modificado, artigo e método para produzir uma composição de polímero modificado | |
| BR112013008008A2 (pt) | composto, composição farmacêutica e processo para preparar um composto | |
| BRPI1006129A2 (pt) | composição de revestimento, processo para produzir uma composição de revestimento, e, laminado. | |
| BRPI0905847A2 (pt) | "composição farmacêutica injetável e processo para preparar a composição" | |
| BRPI0925100A2 (pt) | forma de dosagem osmótica e processo para preparar uma forma de dosagem osmótica | |
| BR112012014023A2 (pt) | mistura polimérica, artigo e método para preparar uma mistura polimérica | |
| BRPI1011888A2 (pt) | processo para preparar um composto, e, composição. | |
| BRPI0910545A2 (pt) | processo contínuo para fazer composições farmacêuticas | |
| CO6801754A2 (es) | Una composición farmacéutica para tratar una enfermedad en la cavidad oral que comprende rebamipida | |
| ZA201108292B (en) | New compounds,pharmaceutical composition and methods relating thereto |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] | ||
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2543 DE 01-10-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |